CDKN2A and neoplasm: Within this panel, we identified a hypermethylated region downstream of the CDKN2A gene that was associated with p16 protein expression in OPSCC and is correlated with an increase in tumor-specific expression of the CDKN2A transcript variant p14(ARF).